EVP, Chief Financial Officer
Mon, Jul 22, 2024
Jul 22
received an award in NTLA
66,324 shares @ $0.00
New position
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
NTLAIntellia Therapeutics, Inc.
Health CareDiagnostics & Research
1D0.00%
1W+6.20%
1M+19.66%
3M+1.82%
6M—
1Y—